The 340B Drug Pricing Program has provided financial help to safety-net hospitals and clinics for over 25 years to manage rising prescription drug costs and preserve access to needed health care services. Under the federal 340B program, pharmaceutical manufacturers participating in Medicaid are required to sell outpatient drugs at discounted prices to eligible health care organizations that care for a large percentage of uninsured and low-income patients. This creates cost-savings opportunities for patients.